Terms: = Thyroid cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
4 results:
1. Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer.
Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-196a-5p targeting lrp1b modulates phenotype of thyroid carcinoma cells.
Hu Y; Zhang C; Chang Q; Du J; Lu H; Guo X; Chang W; Liu S; Chen C
Endokrynol Pol; 2023; 74(2):144-152. PubMed ID: 36916542
[TBL] [Abstract] [Full Text] [Related]
3. A robust biomarker of differential correlations improves the diagnosis of cytologically indeterminate thyroid cancers.
Gomez-Rueda H; Palacios-Corona R; Gutiérrez-Hermosillo H; Trevino V
Int J Mol Med; 2016 May; 37(5):1355-62. PubMed ID: 27035928
[TBL] [Abstract] [Full Text] [Related]
4. Chromosomal, epigenetic and microRNA-mediated inactivation of lrp1b, a modulator of the extracellular environment of thyroid cancer cells.
Prazeres H; Torres J; Rodrigues F; Pinto M; Pastoriza MC; Gomes D; Cameselle-Teijeiro J; Vidal A; Martins TC; Sobrinho-Simões M; Soares P
Oncogene; 2011 Mar; 30(11):1302-17. PubMed ID: 21057533
[TBL] [Abstract] [Full Text] [Related]
